Victoria Clendaniel

Plain English
This study looked at how blocking a protein called HDAC3 can help reduce swelling in the brain and protect the blood-brain barrier after a stroke. The researchers found that using an HDAC3 blocker called RGFP966 within 2 hours of a stroke greatly reduced brain swelling and leakage from blood vessels, leading to better neurological scores. Specifically, it decreased swelling significantly (by about 0.002 on the measurement scale) and led to an increase in protective proteins in the brain. Who this helps: This helps stroke patients by potentially improving their recovery and brain health.

Plain English
Researchers used a gene-editing tool called CRISPR to permanently disable a gene in monkeys' livers that controls cholesterol production, delivering it through tiny fat particles injected into the bloodstream. After a single injection, the monkeys' cholesterol dropped by about 60% and stayed low for at least 8 months without any additional treatment. This proves that gene editing could offer heart disease patients a one-time treatment instead of taking cholesterol drugs for life.

Plain English
This study looked at the effects of a drug that inhibits a protein called HDAC3 in rats who had experienced a stroke. Researchers found that using this drug improved the rats' long-term recovery and reduced brain damage significantly—specifically, the damaged area was smaller by over 99%, while better brain function was linked to increased levels of a marker for healthy brain activity. These findings are important because they suggest a new treatment approach that could help protect the brain and improve recovery after a stroke. Who this helps: Patients recovering from strokes.